ANDREW A PIEPER, MD
Psychiatric at Hawkins Dr, Iowa City, IA
License number
Iowa M3358
Category
Psychiatric
Type
Psychiatry
License number
Iowa 40699
Category
Psychiatric
Type
Psychiatry
Address
Address
200 Hawkins Dr, Iowa City, IA 52242
Phone
(319) 353-5781
(319) 356-2587 (Fax)
(319) 356-2587 (Fax)
Organization information
See more information about ANDREW A PIEPER at bizstanding.comAndrew A Pieper MD
200 Hawkins Dr, Iowa City, IA 52242
Categories:
Physicians & Surgeons
Phone:
(319) 384-8442 (Phone)
Professional information
Dr. Andrew A Pieper, Iowa City IA - MD (Doctor of Medicine)
Specialties:
Psychiatry
Address:
200 Hawkins Dr, Iowa City 52242
(319) 353-5781 (Phone), (319) 356-2587 (Fax)
UNIVERSITY OF IOWA HOSPITALS AND CLINICS
200 Hawkins Dr, Iowa City 52242
(800) 777-8442 (Phone), (319) 356-7533 (Fax)
Dallas
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 645-0078 (Fax)
(319) 353-5781 (Phone), (319) 356-2587 (Fax)
UNIVERSITY OF IOWA HOSPITALS AND CLINICS
200 Hawkins Dr, Iowa City 52242
(800) 777-8442 (Phone), (319) 356-7533 (Fax)
Dallas
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 645-0078 (Fax)
Certifications:
Psychiatry, 2007
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
200 Hawkins Dr, Iowa City 52242
UNIVERSITY OF IOWA HOSPITALS AND CLINICS
200 Hawkins Dr, Iowa City 52242
Dallas
5323 Harry Hines Blvd, Dallas 75390
Parkland Health and Hospital System
5201 Harry Hines Blvd, Dallas 75235
UNIVERSITY OF IOWA HOSPITALS AND CLINICS
200 Hawkins Dr, Iowa City 52242
Dallas
5323 Harry Hines Blvd, Dallas 75390
Parkland Health and Hospital System
5201 Harry Hines Blvd, Dallas 75235
Education:
Medical School
Johns Hopkins Univ Sch Of Med
Graduated: 1996
Johns Hopkins Univ Sch Of Med
Graduated: 1996
Methods For Treating Parkinson's Disease Using Pro-Neurogenic Compounds
US Patent:
2013018, Jul 18, 2013
Filed:
Feb 19, 2013
Appl. No.:
13/770706
Inventors:
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM - Austin TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
Assignee:
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
C07D 487/04, C07D 401/06, C07D 403/12, C07D 209/08, C07D 471/04, C07D 209/88, C07D 413/06
US Classification:
5142328, 514411, 514339, 514376, 514415, 514292, 514275, 514267
Abstract:
This technology relates generally to compounds and methods for stimulating neurogenesis (e.g., post-natal neurogenesis, including post-natal hippocampal and hypothalamic neurogenesis) and/or protecting neuronal cell from cell death. Various compounds are disclosed herein. In vivo activity tests suggest that these compounds may have therapeutic benefits in neuropsychiatric and/or neurodegenerative diseases such as schizophrenia, major depression, bipolar disorder, normal aging, epilepsy, traumatic brain injury, post-traumatic stress disorder, Parkinson's disease, Alzheimer's disease, Down syndrome, spinocerebellar ataxia, amyotrophic lateral sclerosis, Huntington's disease, stroke, radiation therapy, chronic stress, abuse of a neuro-active drug, retinal degeneration, spinal cord injury, peripheral nerve injury, physiological weight loss associated with various conditions, as well as cognitive decline associated with normal aging, chemotherapy, and the like.
Methods For Treating Amyotrophic Lateral Sclerosis Using Pro-Neurogenic Compounds
US Patent:
2013019, Jul 25, 2013
Filed:
Feb 19, 2013
Appl. No.:
13/770676
Inventors:
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM - Austin TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
Assignee:
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
C07D 209/56, C07D 413/06, C07D 487/04, C07D 405/12, C07D 401/12, C07D 403/06, C07D 495/04, C07F 5/02, C07D 471/04
US Classification:
514 64, 5142328, 514267, 514275, 514292, 514339, 514381, 514388, 514406, 514411
Abstract:
This technology relates generally to compounds and methods for stimulating neurogenesis (e.g., post-natal neurogenesis, including post-natal hippocampal and hypothalamic neurogenesis) and/or protecting neuronal cell from cell death. Various compounds are disclosed herein. In vivo activity tests suggest that these compounds may have therapeutic benefits in neuropsychiatric and/or neurodegenerative diseases such as schizophrenia, major depression, bipolar disorder, normal aging, epilepsy, traumatic brain injury, post-traumatic stress disorder, Parkinson's disease, Alzheimer's disease, Down syndrome, spinocerebellar ataxia, amyotrophic lateral sclerosis, Huntington's disease, stroke, radiation therapy, chronic stress, abuse of a neuro-active drug, retinal degeneration, spinal cord injury, peripheral nerve injury, physiological weight loss associated with various conditions, as well as cognitive decline associated with normal aging, chemotherapy, and the like.
Methods Of Treating Traumatic Brain Injury Using Pro-Neurogenic Compounds
US Patent:
2013018, Jul 18, 2013
Filed:
Jan 14, 2013
Appl. No.:
13/740807
Inventors:
Board of Regents of the University of Texas System - Austin TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
Assignee:
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
C07D 471/04, C07D 403/12, C07D 413/06, C07D 209/14, C07D 209/88, C07D 401/06
US Classification:
514275, 514411, 514339, 514376, 514415, 514300
Abstract:
This invention relates generally to stimulating neurogenesis (e.g., post-natal neurogenesis, e.g., post-natal hippocampal neurogenesis) and protecting from neuron cell death.
Pro-Neurogenic Compounds
US Patent:
2013004, Feb 14, 2013
Filed:
Aug 24, 2012
Appl. No.:
13/594223
Inventors:
Steven L. McKnight - Dallas TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
International Classification:
C07D 209/58, C07D 401/06, A61K 31/4439, C07D 413/06, A61K 31/422, C07D 209/08, C07D 471/14, A61K 31/437, C07D 403/06, C07D 401/12, C07D 403/12, A61K 31/506, A61K 31/4192, A61K 31/4155, C07D 405/12, A61P 25/28, A61P 25/18, A61P 25/24, A61P 25/08, A61P 25/16, A61P 25/14, A61K 31/403
US Classification:
514275, 548444, 514411, 5462774, 514339, 548229, 514376, 548509, 514415, 546 87, 514292, 5462767, 544331, 548255, 5483647, 514406, 548443
Abstract:
This technology relates generally to compounds and methods for stimulating neurogenesis (e.g., post-natal neurogenesis, including post-natal hippocampal and hypothalamic neurogenesis) and/or protecting neuronal cell from cell death. Various compounds are disclosed herein. In vivo activity tests suggest that these compounds may have therapeutic benefits in neuropsychiatric and/or neurodegenerative diseases such as schizophrenia, major depression, bipolar disorder, normal aging, epilepsy, traumatic brain injury, post-traumatic stress disorder, Parkinson's disease, Alzheimer's disease, Down syndrome, spinocerebellar ataxia, amyotrophic lateral sclerosis, Huntington's disease, stroke, radiation therapy, chronic stress, abuse of a neuro-active drug, retinal degeneration, spinal cord injury, peripheral nerve injury, physiological weight loss associated with various conditions, as well as cognitive decline associated with normal aging, chemotherapy, and the like.
Pro-Neurogenic Compounds
US Patent:
2014005, Feb 27, 2014
Filed:
Aug 23, 2013
Appl. No.:
13/974642
Inventors:
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Enrique Fernandez - Dallas TX, US
Joseph M. Ready - Carrollton TX, US
Enrique Fernandez - Dallas TX, US
Assignee:
Board of Regents of The University of Texas System - Austin TX
International Classification:
C07D 471/04, C07D 403/06, C07D 209/90, C07D 405/06, C07D 223/24, C07D 487/04
US Classification:
514217, 514267, 514292, 514411, 540591, 544250, 546 84, 548444
Abstract:
Compounds and methods for stimulating neurogenesis (e.g., post-natal neurogenesis, including post-natal hippocampal and hypothalamic neurogenesis) and/or protecting neuronal cell from cell death are disclosed herein. In vivo activity tests suggest that these compounds may have therapeutic benefits in neuropsychiatric and/or neurodegenerative diseases such as schizophrenia, major depression, bipolar disorder, normal aging, epilepsy, traumatic brain injury, post-traumatic stress disorder, Parkinson's disease, Alzheimer's disease, Down syndrome, spinocerebellar ataxia, amyotrophic lateral sclerosis, Huntington's disease, stroke, radiation therapy, chronic stress, abuse of a neuro-active drug, retinal degeneration, spinal cord injury, peripheral nerve injury, physiological weight loss associated with various conditions, as well as cognitive decline associated with normal aging, chemotherapy, and the like.
Methods Of Treating Post-Traumatic Stress Disorder Using Pro-Neurogenic Compounds
US Patent:
2013018, Jul 18, 2013
Filed:
Jan 14, 2013
Appl. No.:
13/740876
Inventors:
Board of Regents of the University of Texas System - Austin TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
Assignee:
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
C07D 471/04, C07D 403/12, C07D 413/06, C07D 209/08, C07D 209/88, C07D 401/06
US Classification:
514275, 514411, 514339, 514376, 514415, 514292
Abstract:
This invention relates generally to stimulating neurogenesis (e.g., post-natal neurogenesis, e.g., post-natal hippocampal neurogenesis) and protecting from neuron cell death.
Pro-Neurogenic Compounds
US Patent:
2013019, Jul 25, 2013
Filed:
Dec 10, 2012
Appl. No.:
13/709531
Inventors:
Board of Regents of the University of Texas System - Austin TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
Andrew A. Pieper - Iowa City IA, US
Joseph M. Ready - Carrollton TX, US
Jef K. De Brabander - Flower Mound TX, US
Assignee:
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
C07D 209/88, C07D 413/06, C07D 403/06, C07D 471/04, C07D 403/12, C07D 401/06, C07D 209/08
US Classification:
514275, 548444, 514411, 5462767, 514339, 548231, 514376, 548509, 514415, 546 87, 514292, 544331, 548255, 514406
Abstract:
This invention relates generally to stimulating neurogenesis (e.g., post-natal neurogenesis, e.g., post-natal hippocampal neurogenesis) and protecting from neuron cell death.